CSPC listed 4th inChina pharmaceutical industry top list in 2018.

2 Aug 2019

CSPC listed 4th inChina pharmaceutical industry top list in 2018.

CSPC has a total asset of RMB 41 billion and around 25,000 employees up to now. Listed in Hong Kong(01093.HK)with market value of more than HK$ 100 billion and being one of the Hang Seng Index constituent stocks, CSPC has been the first pharmaceutical share since the past 50 years.

CSPC listed 4th inChina pharmaceutical industry top list in 2018.
China pharmaceutical industry top list in 2018.

As the Chinese leading pharmaceutical enterprise ,CSPC is engaged in development, production and sale.The key products include seven branches and nearly 1,000 varieties, such as antibiotic, vitamin, cardiovascular and cerebrovascular medicine, antipyretic and analgesic one, digestive system medicine and antineoplastic .The sales of 30 single-variety products has exceeded RMB 100 million respectively.

What's more,CSPC is listed in Top 10 Asian Pharmaceutical Companiesin Sales Revenue, and its products are sold throughout China and more than 60 countries and regions in the world. In 2018, Institutional Investor, an international authoritative financial magazine, presented the latest annual ranking list in which CSPC was awarded The Most Respected Enterprise in the rating ofCompany Management Team in Asia 2018. In 2017, the total export value reached to USD 600 million and CSPC ranked first among China’s exports of health care products.

Read More